GB1359226A - Propylene carbonate medicament base composition - Google Patents
Propylene carbonate medicament base compositionInfo
- Publication number
- GB1359226A GB1359226A GB4193171A GB4193171A GB1359226A GB 1359226 A GB1359226 A GB 1359226A GB 4193171 A GB4193171 A GB 4193171A GB 4193171 A GB4193171 A GB 4193171A GB 1359226 A GB1359226 A GB 1359226A
- Authority
- GB
- United Kingdom
- Prior art keywords
- weight percent
- alkyl
- alcohols
- propylene carbonate
- polysiloxane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Abstract
1359226 Medicament base compositions SYNTEX CORP 8 Sept 1971 [29 Oct 1970] 41932/71 Heading A5B A composition, useful as a medicament base, consists essentially of (a) from 0.1 to 30 weight percent propylene carbonate; b) from 30 to 99.5 weight percent petrolatum or polysiloxane or mixtures thereof; c) compatible cosolvent and coupling agent, the concentration of which in combination with the propylene carbonate is from 0.5 to 70 weight percent; (d) from 0 to 45 weight percent pharmaceutically acceptable surfactant; (e) from 0 to 20 weight percent thickener: and (f) from 0 to 25 weight percent penetrant. The pentrolatum may be a paraffinic mineral oil or paraffin wax; and the polysiloxane may have organic moieties such as C 1-8 alkyl, C 1-8 alkenyl, phenyl, alkyl-substituted phenyl, and phenyl alkyl (e.g. benzyl) attached to the polysiloxane, dimethylpolysolixane being preferred; the compatible cosolvent and coupling agent may be chosen from mono-, di- or poly-hydric alcohols, alkyl ethers of glycols, polyethylene or polypropylene glycol, esters of aliphatic mono- and di-basic acids and mono-, di- and polyhydric alcohols, sugar alcohols or a sterol such as cholesterol; the surfactant may be anionic, cationic, amphoteric or nonionic; the thickener may be colloidal alumina or silica, alginic acid or derivatives thereof, carboxyvinyl polymer, cellulose derivatives (such as methyl cellulose, hydroxyethyl cellulose or sodium carboxymethyl cellulose), gelatin, gums (such as agar, tragacanth, acacia or guar gum), egg yolk, lecithin, pectin, thixcin or resins (such as ethyleneoxide polymers); and the penetrant may be a dialkyl sulphoxide, dimethyl-formamide, dimethylacetamide, tetrahydrofuran or tetrahydrofurfuryl alcohol. The composition may also contain beeswax, spermaceti, paraffin waxes, fatty acids, alcohols and amides; a penetration aid such as squalene or acetylated lanolin fractions and/or a preservative. The composition may contain a therapeutic agent for topical application such as an antibiotic, e.g. oxytetracylcline, chlorotetracycline, streptomycin, bacitracin, chloramphenicol or tyrothricin; a steroid; an antihistamine such as prophenpyridamine maleate or diphenhydramine hydrochloride; an anaesthetic such as benzocaine or lidocaine; an antibacterial such as iodine, nitrofurazone, sulphanilamide and derivatives, or benzalkonium chloride; a fungicide such as undecylenic acid; coal tar, balsum Peru, ammoniated mercury, chrysarobin, ichthammol or sulphur.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8524670A | 1970-10-29 | 1970-10-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1359226A true GB1359226A (en) | 1974-07-10 |
Family
ID=22190384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4193171A Expired GB1359226A (en) | 1970-10-29 | 1971-09-08 | Propylene carbonate medicament base composition |
Country Status (17)
Country | Link |
---|---|
JP (1) | JPS5410613B1 (en) |
AT (1) | AT310948B (en) |
BE (1) | BE774489A (en) |
CA (1) | CA989306A (en) |
CH (1) | CH566783A5 (en) |
DE (1) | DE2153779C3 (en) |
DK (1) | DK129766B (en) |
ES (2) | ES396479A1 (en) |
FI (1) | FI52811C (en) |
FR (1) | FR2111912B1 (en) |
GB (1) | GB1359226A (en) |
IL (1) | IL37614A (en) |
NL (1) | NL164199C (en) |
NO (1) | NO133998C (en) |
SE (1) | SE377042B (en) |
YU (1) | YU268471A (en) |
ZA (1) | ZA715709B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2116423A (en) * | 1982-01-13 | 1983-09-28 | Quinoderm Ltd | Dermatological compositions |
US4626529A (en) * | 1981-10-23 | 1986-12-02 | L'oreal | Oily compositions comprising a dermatological active principle, intended for the treatment of the scalp or skin |
EP2319510A1 (en) * | 2009-10-02 | 2011-05-11 | Johnson and Johnson Consumer Companies, Inc. | Benzoyl peroxide composition for treating skin |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1327853A (en) * | 1971-05-24 | 1973-08-22 | Ici Ltd | Griseofulvin compositions |
FR2205358B1 (en) * | 1972-11-03 | 1976-04-23 | Rhone Poulenc Ind | |
US4070462A (en) * | 1976-10-26 | 1978-01-24 | Schering Corporation | Steroid ointment |
-
1971
- 1971-08-25 CA CA121,282A patent/CA989306A/en not_active Expired
- 1971-08-26 ZA ZA715709A patent/ZA715709B/en unknown
- 1971-08-30 IL IL37614A patent/IL37614A/en unknown
- 1971-09-08 GB GB4193171A patent/GB1359226A/en not_active Expired
- 1971-09-23 DK DK464371AA patent/DK129766B/en not_active IP Right Cessation
- 1971-09-23 NO NO3529/71A patent/NO133998C/no unknown
- 1971-10-12 FI FI712857A patent/FI52811C/en active
- 1971-10-19 AT AT902771A patent/AT310948B/en not_active IP Right Cessation
- 1971-10-20 JP JP8254271A patent/JPS5410613B1/ja active Pending
- 1971-10-22 YU YU02684/71A patent/YU268471A/en unknown
- 1971-10-26 BE BE774489A patent/BE774489A/en not_active IP Right Cessation
- 1971-10-27 FR FR7138662A patent/FR2111912B1/fr not_active Expired
- 1971-10-28 SE SE7113702A patent/SE377042B/xx unknown
- 1971-10-28 ES ES396479A patent/ES396479A1/en not_active Expired
- 1971-10-28 DE DE2153779A patent/DE2153779C3/en not_active Expired
- 1971-10-29 CH CH1581771A patent/CH566783A5/xx not_active IP Right Cessation
- 1971-10-29 NL NL7114957.A patent/NL164199C/en not_active IP Right Cessation
-
1974
- 1974-02-16 ES ES423345A patent/ES423345A1/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4626529A (en) * | 1981-10-23 | 1986-12-02 | L'oreal | Oily compositions comprising a dermatological active principle, intended for the treatment of the scalp or skin |
GB2116423A (en) * | 1982-01-13 | 1983-09-28 | Quinoderm Ltd | Dermatological compositions |
EP2319510A1 (en) * | 2009-10-02 | 2011-05-11 | Johnson and Johnson Consumer Companies, Inc. | Benzoyl peroxide composition for treating skin |
Also Published As
Publication number | Publication date |
---|---|
NL164199C (en) | 1980-12-15 |
ZA715709B (en) | 1972-11-29 |
DE2153779B2 (en) | 1974-08-29 |
CA989306A (en) | 1976-05-18 |
YU268471A (en) | 1984-06-30 |
IL37614A (en) | 1974-05-16 |
AT310948B (en) | 1973-10-25 |
CH566783A5 (en) | 1975-09-30 |
FR2111912B1 (en) | 1975-02-07 |
NO133998C (en) | 1976-08-04 |
DK129766B (en) | 1974-11-18 |
JPS5410613B1 (en) | 1979-05-08 |
ES396479A1 (en) | 1975-02-16 |
BE774489A (en) | 1972-02-14 |
NO133998B (en) | 1976-04-26 |
SE377042B (en) | 1975-06-23 |
DE2153779C3 (en) | 1975-04-24 |
AU3322871A (en) | 1973-03-15 |
DK129766C (en) | 1975-04-28 |
ES423345A1 (en) | 1976-06-01 |
FI52811B (en) | 1977-08-31 |
FR2111912A1 (en) | 1972-06-09 |
FI52811C (en) | 1977-12-12 |
IL37614A0 (en) | 1971-11-29 |
NL7114957A (en) | 1972-05-03 |
DE2153779A1 (en) | 1972-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4195085A (en) | Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate | |
KR890701084A (en) | Composition and administration method of eye drops cyclospoorin | |
LU90677I2 (en) | Esomeprazole and its pharmaceutically acceptable salts and derivatives (nexiam) | |
HUT49280A (en) | Ointment for the peroral administration of medicine and process for producing the composition | |
KR890015729A (en) | Anesthetic skin moisturizing composition and preparation method thereof | |
DE3065420D1 (en) | Pharmaceutical composition containing sanguinaria and galangal suitable for treatment of periodentitis and tumours | |
IL58775A (en) | Hydroxyethyl-azole compounds,their production and pharmaceutical compositions containing them | |
IL58782A (en) | Hydroxypropyl-triazole compounds,their production and pharmaceutical compositions containing them | |
GB1359226A (en) | Propylene carbonate medicament base composition | |
US2730483A (en) | Therapeutic compositions comprising neomycin, gramicidin and quaternary ammonium salt of thonzylamine | |
US3888995A (en) | Fatty alcohol-propylene glycol vehicle | |
ATE41012T1 (en) | (8S)-8-FLUOROERYTHROMYCIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
KR850000974A (en) | Process for preparing pharmaceutical composition containing liquid lubricant | |
IE40957L (en) | 4- o-ó,d-glucopyranosyl -6-o-ó,d- xylohexopyranosyl -2-¹deoxystreptamine | |
KR900016156A (en) | Quinoxaline derivatives and ulcers | |
GB1183299A (en) | Foam Bath Compositions | |
GB1454389A (en) | Nasal decongestants nasal decongestants | |
IE44167B1 (en) | Ophthalmic compositions | |
IT1164677B (en) | 1,3 BENZODIOXY DERIVATIVES PROCEDURE FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AS ACTIVE INCREDIENTS | |
GB843134A (en) | Improvements in and relating to pharmaceutical compositions | |
HUT59597A (en) | Process for producing pharmaceutical compositions contaiing pharmaceutically active tetrahydro-naphtalene derivatives | |
GB2012166A (en) | Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts. | |
ES8401483A1 (en) | Furobenzazepines, their production and pharmaceutical compositions containing them | |
BE882020A (en) | SUBSTITUTED BENZHYDRINDANES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
RU94027137A (en) | Medicinal vaseline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PE20 | Patent expired after termination of 20 years |